Multivariate analysis showed that the HCC imaging no-show rate and HCC imaging delay remained independent risk factors for TTP when accounting for Milan criteria, AFP levels, albumin levels, and first-cycle LDT response rates, regardless of transplant track status (Table 6). The gene discussed is AFP; the disease is hepatocellular carcinoma.